Tango Therapeutics TNGX Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's operating lease liabilities (current)?
- Tango Therapeutics (TNGX) reported operating lease liabilities (current) of $2.83M in Q1 2026.
- How has Tango Therapeutics's operating lease liabilities (current) changed year-over-year?
- Tango Therapeutics's operating lease liabilities (current) increased by 0.3% year-over-year, from $2.82M to $2.83M.
- What is the long-term trend for Tango Therapeutics's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Tango Therapeutics's operating lease liabilities (current) has grown at a 23.3% compound annual growth rate (CAGR), from $959K to $2.74M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.